Press Releases Celldex Therapeutics, Inc.

Equities

CLDX

US15117B2025

Market Closed - Nasdaq Other stock markets 01:30:00 27/04/2024 am IST			5-day change	1st Jan Change
36.3 ^USD	+0.11%		-4.42%	-8.47%

17/04	Sector Update: Health Care Stocks Mixed Wednesday Afternoon	MT
17/04	Celldex Therapeutics Says Patient Enrollment Completed in Chronic Inducible Urticaria Treatment Study; Shares Rise	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Celldex Therapeutics : Corporate Presentation	17/04	PU
Celldex Announces Completion of Enrollment in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible Urticaria	17/04	AQ
Celldex Therapeutics to Participate in the Leerink Partners Global Biopharma Conference	08/03	AQ
Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares	06/03	AQ
Celldex Therapeutics to Present at TD Cowen's 44th Annual Health Care Conference	06/03	AQ
Celldex Therapeutics to Present at TD Cowen’s 44th Annual Health Care Conference	05/03	AQ
Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares	05/03	AQ
Celldex Therapeutics Announces Pricing of Upsized $400 Million Public Offering of Common Stock	01/03	AQ
Celldex Therapeutics Announces Proposed Public Offering of Common Stock	29/02	AQ
Celldex Therapeutics Presents Positive 12 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria	26/02	AQ
Celldex: Q4 Earnings Snapshot	26/02	AQ
Celldex Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update	26/02	AQ
Celldex Therapeutics Presents Positive 12 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria	25/02	AQ
Celldex to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference	07/02	AQ
Celldex Announces Upcoming Presentation of Barzolvolimab Phase 2 Results in Chronic Spontaneous Urticaria at AAAAI 2024	05/02	AQ
Celldex Therapeutics to Present at 6th Annual Evercore ISI HealthCONx Conference	28/11	AQ
GREAT NEWS FOR SUFFERERS FROM HIVES: Congratulations To The Team At Celldex Therapeutics	09/11	AQ
Celldex Therapeutics Announces Pricing of Public Offering of Common Stock	08/11	AQ
Celldex Therapeutics Announces Proposed Public Offering of Common Stock	08/11	AQ
Freshpet, Celldex Therapeutics rise; TreeHouse Foods, Dish Network fall, Monday, 11/6/2023	07/11	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Celldex Therapeutics, Inc.

Equities

CLDX

US15117B2025

Press Releases

Filters